These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33408345)
1. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool. Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345 [TBL] [Abstract][Full Text] [Related]
2. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells. Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814 [TBL] [Abstract][Full Text] [Related]
3. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression. Simonetta F; Gestermann N; Bloquet S; Bourgeois C PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946 [TBL] [Abstract][Full Text] [Related]
6. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. Cheng G; Yu A; Dee MJ; Malek TR J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074 [TBL] [Abstract][Full Text] [Related]
7. Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function. Hayes ET; Hagan CE; Khoryati L; Gavin MA; Campbell DJ J Immunol; 2020 Nov; 205(10):2667-2678. PubMed ID: 33055282 [TBL] [Abstract][Full Text] [Related]
8. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. Bayer AL; Yu A; Malek TR J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960 [TBL] [Abstract][Full Text] [Related]
9. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253 [TBL] [Abstract][Full Text] [Related]
10. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757 [TBL] [Abstract][Full Text] [Related]
12. Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development. Zhang H; Dai D; Hu Q; Yang F; Xue Y; Li F; Shen N; Zhang M; Huang C Cell Rep; 2021 May; 35(6):109096. PubMed ID: 33979619 [TBL] [Abstract][Full Text] [Related]
13. Essential and non-overlapping IL-2Rα-dependent processes for thymic development and peripheral homeostasis of regulatory T cells. Toomer KH; Lui JB; Altman NH; Ban Y; Chen X; Malek TR Nat Commun; 2019 Mar; 10(1):1037. PubMed ID: 30833563 [TBL] [Abstract][Full Text] [Related]
14. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction. Liu X; Gao N; Li M; Xu D; Hou Y; Wang Q; Zhang G; Sun Q; Zhang H; Zeng X PLoS One; 2013; 8(6):e64531. PubMed ID: 23776439 [TBL] [Abstract][Full Text] [Related]
16. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Cheng G; Yu A; Malek TR Immunol Rev; 2011 May; 241(1):63-76. PubMed ID: 21488890 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Chorro L; Suzuki M; Chin SS; Williams TM; Snapp EL; Odagiu L; Labrecque N; Lauvau G Nat Commun; 2018 Dec; 9(1):5368. PubMed ID: 30560927 [TBL] [Abstract][Full Text] [Related]
18. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function. Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372 [TBL] [Abstract][Full Text] [Related]
19. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. Yu A; Malek TR J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695 [TBL] [Abstract][Full Text] [Related]
20. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]